Try our Advanced Search for more refined results
June 04, 2018
Hardy v. Mabvax Therapeutics Holdings et al
Case Number:
3:18-cv-01160
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 05, 2018
SEC Probe Into Biotech Co. Made Shares Drop, Investor Says
An investor in the biotechnology company Mabvax Therapeutics Holdings lodged a proposed class action in California federal court Monday, alleging the company's failure to disclose control issues and improper influence by some investors sparked a U.S. Securities and Exchange Commission investigation that caused its stock price to plummet.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login